These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 3264789)

  • 21. Linearization correction of 99mTc-labeled hexamethyl-propylene amine oxime (HM-PAO) image in terms of regional CBF distribution: comparison to C15O2 inhalation steady-state method measured by positron emission tomography.
    Inugami A; Kanno I; Uemura K; Shishido F; Murakami M; Tomura N; Fujita H; Higano S
    J Cereb Blood Flow Metab; 1988 Dec; 8(6):S52-60. PubMed ID: 3142888
    [TBL] [Abstract][Full Text] [Related]  

  • 22. SPECT measurements with 99mTc-HM-PAO in focal epilepsy.
    Ryding E; Rosén I; Elmqvist D; Ingvar DH
    J Cereb Blood Flow Metab; 1988 Dec; 8(6):S95-100. PubMed ID: 3142889
    [TBL] [Abstract][Full Text] [Related]  

  • 23. SPECT imaging of moyamoya disease using 99mTc-HM-PAO. Comparison with computed tomography findings.
    Mountz JM; Foster NL; Ackermann RJ; Bluemlein L; Petry NA; Kuhl DE
    J Comput Tomogr; 1988 Oct; 12(4):247-50. PubMed ID: 3264230
    [TBL] [Abstract][Full Text] [Related]  

  • 24. HM-PAO assessment of human tumour perfusion.
    Tait D; McCready VR; Ott RJ
    Eur J Cancer Clin Oncol; 1987 Jun; 23(6):789-93. PubMed ID: 3498633
    [TBL] [Abstract][Full Text] [Related]  

  • 25. SPECT imaging of cerebral perfusion using 99m Tc labelled HM-PAO.
    Davidson J
    Radiography; 1987; 53(610):165-6. PubMed ID: 3499628
    [No Abstract]   [Full Text] [Related]  

  • 26. [Regional cerebrocerebellar perfusion imaging in spinocerebellar degeneration using technetium-99m-HM-PAO].
    Tanaka M; Inoue T; Kawarabayashi T; Hirai S; Sasaki Y
    Rinsho Shinkeigaku; 1988 Jul; 28(7):769-74. PubMed ID: 3266122
    [No Abstract]   [Full Text] [Related]  

  • 27. Evaluation of a 99Tcm bound brain scanning agent for single photon emission computed tomography.
    Andersen AR; Hasselbalch SG; Paulson OB; Lassen NA; Kristensen K; Neirinckx RD
    Acta Radiol Suppl; 1986; 369():456-9. PubMed ID: 2980525
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of regional cerebral blood flow with 99mTc-d, 1 HM-PAO and SPECT.
    Neirinckx RD
    Neurosurg Rev; 1987; 10(3):181-4. PubMed ID: 3332036
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CBF tomograms with [99mTc-HM-PAO in patients with dementia (Alzheimer type and HIV) and Parkinson's disease--initial results.
    Costa DC; Ell PJ; Burns A; Philpot M; Levy R
    J Cereb Blood Flow Metab; 1988 Dec; 8(6):S109-15. PubMed ID: 3263977
    [TBL] [Abstract][Full Text] [Related]  

  • 30. HM-PAO in clinical practice.
    Podreka I
    Nucl Med Commun; 1987 Jul; 8(7):559-72. PubMed ID: 3500435
    [No Abstract]   [Full Text] [Related]  

  • 31. Does the washout phenomenon of Tc-99m HM-PAO correlate to the "filling-in" phenomenon of I-123 IMP with brain SPECT?
    Hayashida K; Nishimura T; Imakita S; Uehara T
    Neuroradiology; 1990; 32(3):196-9. PubMed ID: 2215903
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Regional changes in cerebral circulation in epileptic seizure: measurements using 99m Tc-HM-PAO-SPECT].
    Stefan H; Feistel H; Bauer J; Erbguth F; Wolf F; Neundörfer B
    Nervenarzt; 1988 May; 59(5):299-303. PubMed ID: 3136403
    [No Abstract]   [Full Text] [Related]  

  • 33. The use of technetium-99m-HM-PAO in the assessment of patients with dementia and other neuropsychiatric conditions.
    Smith FW; Besson JA; Gemmell HG; Sharp PF
    J Cereb Blood Flow Metab; 1988 Dec; 8(6):S116-22. PubMed ID: 2973469
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Technetium-99m-d, 1-HM-PAO: a new radiopharmaceutical for imaging regional brain perfusion using SPECT--a comparison with iodine-123 HIPDM.
    Leonard JP; Nowotnik DP; Neirinckx RD
    J Nucl Med; 1986 Dec; 27(12):1819-23. PubMed ID: 3491188
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Evaluation of the clinical usefulness of super dynamic 99mTc-HM-PAO SPECT in ischemic cerebrovascular disease--detection of hypo- and hyperperfusion area].
    Toyama H; Takeshita G; Shibata K; Nomura M; Fujiwara T; Ishikawa E; Fujiwara M; Fujii N; Ejiri K; Maeda H; Katada K; Takeuchi A; Koga S
    Kaku Igaku; 1996 May; 33(5):521-9. PubMed ID: 8699620
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Initial experience with Tc-99m-HM-PAO in the study of brain tumors.
    Babich JW; Keeling F; Flower MA; Repetto L; Whitton A; Fielding S; Fullbrook A; Ott RJ; McCready VR
    Eur J Nucl Med; 1988; 14(1):39-44. PubMed ID: 2838284
    [TBL] [Abstract][Full Text] [Related]  

  • 37. HM-PAO: a new technetium-99m labelled agent for brain SPECT.
    Costa DC; Ell PJ; Nowotnik DP
    J Nucl Med Allied Sci; 1985; 29(4):337-8. PubMed ID: 3879691
    [No Abstract]   [Full Text] [Related]  

  • 38. A comparison of Tc-99m HM-PAO and I-123 IMP cerebral SPECT images in Alzheimer's disease and multi-infarct dementia.
    Gemmell HG; Sharp PF; Besson JA; Ebmeier KP; Smith FW
    Eur J Nucl Med; 1988; 14(9-10):463-6. PubMed ID: 3265101
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cerebral and cerebellar uptake of 99mTc-(d,1)-hexamethyl-propyleneamine oxime (HM-PAO) in patients with brain tumor studied by single photon emission computerized tomography.
    Lindegaard MW; Skretting A; Hager B; Watne K; Lindegaard KF
    Eur J Nucl Med; 1986; 12(9):417-20. PubMed ID: 3493139
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Blood flow imaging of a posterior circulation stroke. Use of technetium Tc 99m hexamethylpropyleneamine oxime and single photon emission computed tomography.
    Foster NL; Mountz JM; Bluelein LA; Ackermann RJ; Petry NA; Kuhl DE
    Arch Neurol; 1988 Jun; 45(6):687-90. PubMed ID: 3259422
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.